CRISPR-Cas9 and Optogenetics Converge

Japanese researchers led by University of Tokyo chemist Moritoshi Sato have refined the CRISPR-Cas9 method by developing a light-activated Cas9 nuclease, a technological advancement that significantly improves scientists’ ability to hone in on target genes for research. Converging these two methods brings specificity on a new level, making for increased spatial and temporal control over…